Silva Pharmaceuticals Statistics

Total Valuation

DSE:SILVAPHL has a market cap or net worth of BDT 1.32 billion. The enterprise value is 1.23 billion.

Market Cap	1.32B
Enterprise Value	1.23B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Dec 2, 2024

Share Statistics

DSE:SILVAPHL has 136.50 million shares outstanding.

Current Share Class	136.50M
Shares Outstanding	136.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.07
PB Ratio	0.61
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	218.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.31
EV / Sales	2.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-49.22

Financial Position

The company has a current ratio of 12.63, with a Debt / Equity ratio of 0.02.

Current Ratio	12.63
Quick Ratio	5.50
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-1.67
Interest Coverage	-20.46

Financial Efficiency

Return on equity (ROE) is -5.87% and return on invested capital (ROIC) is -3.10%.

Return on Equity (ROE)	-5.87%
Return on Assets (ROA)	-2.96%
Return on Invested Capital (ROIC)	-3.10%
Return on Capital Employed (ROCE)	-5.03%
Revenue Per Employee	627,448
Profits Per Employee	-191,225
Employee Count	596
Asset Turnover	0.18
Inventory Turnover	0.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.13% in the last 52 weeks. The beta is 0.03, so DSE:SILVAPHL's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-44.13%
50-Day Moving Average	11.12
200-Day Moving Average	11.67
Relative Strength Index (RSI)	34.49
Average Volume (20 Days)	98,615

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SILVAPHL had revenue of BDT 431.68 million and -131.56 million in losses. Loss per share was -0.96.

Revenue	431.68M
Gross Profit	115.14M
Operating Income	-113.42M
Pretax Income	-113.08M
Net Income	-131.56M
EBITDA	-54.89M
EBIT	-113.42M
Loss Per Share	-0.96

Full Income Statement

Balance Sheet

The company has 140.44 million in cash and 41.47 million in debt, giving a net cash position of 98.97 million or 0.73 per share.

Cash & Cash Equivalents	140.44M
Total Debt	41.47M
Net Cash	98.97M
Net Cash Per Share	0.73
Equity (Book Value)	2.17B
Book Value Per Share	15.91
Working Capital	819.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.05 million and capital expenditures -30.94 million, giving a free cash flow of -24.89 million.

Operating Cash Flow	6.05M
Capital Expenditures	-30.94M
Free Cash Flow	-24.89M
FCF Per Share	-0.18

Full Cash Flow Statement

Margins

Gross margin is 26.67%, with operating and profit margins of -26.27% and -30.48%.

Gross Margin	26.67%
Operating Margin	-26.27%
Pretax Margin	-26.20%
Profit Margin	-30.48%
EBITDA Margin	-12.72%
EBIT Margin	-26.27%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.01%.

Dividend Per Share	0.10
Dividend Yield	1.01%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.01%
Earnings Yield	-9.94%
FCF Yield	-1.88%

Dividend Details

Stock Splits

The last stock split was on November 7, 2019. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 7, 2019
Split Type	Forward
Split Ratio	1.05

Scores

DSE:SILVAPHL has an Altman Z-Score of 7.76.

Altman Z-Score	7.76
Piotroski F-Score	n/a